Patrick R. O'neil - 28 Feb 2022 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP CLO & General Counsel
Signature
Patrick R. O'Neil
Issuer symbol
IONS
Transactions as of
28 Feb 2022
Transactions value $
$20,854
Form type
4
Filing time
02 Mar 2022, 17:42:47
Previous filing
20 Jan 2022
Next filing
14 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Other $20.9K +735 +1.81% $28.37 41.3K 28 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on February 28, 2022. These shares may not be sold until August 28, 2022.